FierceBiotechOriginal article
{"a":[{"_":"FDA halts release of new drug rejection letters while working to formalize policy","$":{"href":"/biotech/fda-halts-release-new-drug-rejection-letters-while-working-formalize-policy","hreflang":"en"}}]}
RegulatoryNegative
AI Analysis
Summary
The FDA has paused its policy of releasing drug rejection letters following a citizen petition from an unnamed pharma company in April. The agency is working to formalize its approach to releasing such communications.
Outcome Details
FDA paused release of drug rejection letters following citizen petition
Importance:4/10
Sentiment:
-0.30
FDAregulatory policydrug rejectiontransparencycitizen petition
Related Companies
Read the original article
Published by FierceBiotech on July 8, 2026 1:06 PM
